Results 91 to 100 of about 21,253 (159)

Neurofibromin 1 (<i>NF1</i>) Splicing Mutation c.61-2A>G: From Aberrant mRNA Processing to Therapeutic Implications In Silico. [PDF]

Int J Mol Sci
Blazyte A, Lee H, Yoon C, Jeon S, Lee J, Bayarsaikhan D, Kim J, Park S, Cho J, Baek SA, Byun G, Lee B, Bhak J.   +12 more
europepmc   +1 more source

Inhibition of Cxcr4 chemokine receptor signaling improves habituation learning in a zebrafish model of neurofibromatosis. [PDF]

Dis Model Mech
Miller AH, Yang Y, Schmidt N, Mathiaparanam J, Berres ME, Halloran MC.   +5 more
europepmc   +1 more source

Mind the GAP: A Role for Neurofibromin in Restricting Axonal Plasticity: Figure 1. [PDF]

The Journal of Neuroscience, 2007
Andrew D. Gaudet, Leanne M. Ramer
openaire   +1 more source

Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. [PDF]

PLoS One
Li H, Pemov A, Allaway R, Muir DF, Chang LJ, Banerjee J, Scott AJ, Nagy JMW, Liu J, Carrió M, Mazuelas H, Yachnis A, Lee SY, Zhang X, Lyu Y, Stewart DR, Hirbe A, Blakeley JO, Serra E, Wallis D, Wallace MR.   +20 more
europepmc   +1 more source

Ataluren-Induced Functional Restoration of Neurofibromin in Fibroblasts From Neurofibromatosis Type 1 Patients With Nonsense Mutations. [PDF]

MedComm (2020)
Kim S, Do H, Heo SH, Kang M, Hwang S, Kim D, Chang MH, Kim K, Lee BH.   +8 more
europepmc   +1 more source

Neurofibromatosis Type 1: Genetic Mechanisms and Advances in Therapeutic Innovation. [PDF]

Cancers (Basel)
Lu Y, Xu M, Chen X, Xu H, Sun N, Weisgerber KE, Bai RY.   +6 more
europepmc   +1 more source

High Allelic Heterogeneity in Kazakhstani Patients with Neurofibromatosis Type 1: Results from the First Molecular Study. [PDF]

Genes (Basel)
Idrissova Z, Rakhimbekova F, Orazgaliyeva M, Zhaksybek M, Kovaleva K, Abdikerim S, Ormankyzy A, Vasiluev P.   +7 more
europepmc   +1 more source